nodes	percent_of_prediction	percent_of_DWPC	metapath
Metronidazole—CYP2C8—Mometasone—systemic scleroderma	0.273	0.468	CbGbCtD
Metronidazole—CYP2C9—Leflunomide—systemic scleroderma	0.122	0.21	CbGbCtD
Metronidazole—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.109	0.186	CbGbCtD
Metronidazole—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.044	0.0755	CbGbCtD
Metronidazole—CYP3A4—Prednisone—systemic scleroderma	0.0352	0.0604	CbGbCtD
Metronidazole—CYP2C9—cardial valve—systemic scleroderma	0.00441	0.929	CbGeAlD
Metronidazole—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000269	0.000652	CcSEcCtD
Metronidazole—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000268	0.000651	CcSEcCtD
Metronidazole—Diarrhoea—Captopril—systemic scleroderma	0.000268	0.00065	CcSEcCtD
Metronidazole—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000268	0.00065	CcSEcCtD
Metronidazole—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000268	0.000649	CcSEcCtD
Metronidazole—Irritability—Methotrexate—systemic scleroderma	0.000268	0.000649	CcSEcCtD
Metronidazole—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000267	0.000648	CcSEcCtD
Metronidazole—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000267	0.000647	CcSEcCtD
Metronidazole—Feeling abnormal—Leflunomide—systemic scleroderma	0.000266	0.000646	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000266	0.000645	CcSEcCtD
Metronidazole—Fatigue—Mycophenolic acid—systemic scleroderma	0.000266	0.000644	CcSEcCtD
Metronidazole—Nausea—Mometasone—systemic scleroderma	0.000265	0.000643	CcSEcCtD
Metronidazole—Anorexia—Lisinopril—systemic scleroderma	0.000265	0.000642	CcSEcCtD
Metronidazole—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000264	0.000641	CcSEcCtD
Metronidazole—Ataxia—Methotrexate—systemic scleroderma	0.000264	0.000639	CcSEcCtD
Metronidazole—Constipation—Mycophenolic acid—systemic scleroderma	0.000264	0.000639	CcSEcCtD
Metronidazole—Pain—Mycophenolic acid—systemic scleroderma	0.000264	0.000639	CcSEcCtD
Metronidazole—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000263	0.000639	CcSEcCtD
Metronidazole—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000262	0.000635	CcSEcCtD
Metronidazole—Dizziness—Captopril—systemic scleroderma	0.000259	0.000629	CcSEcCtD
Metronidazole—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000259	0.000628	CcSEcCtD
Metronidazole—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000258	0.000626	CcSEcCtD
Metronidazole—Depression—Prednisone—systemic scleroderma	0.000258	0.000625	CcSEcCtD
Metronidazole—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000257	0.000624	CcSEcCtD
Metronidazole—Urticaria—Leflunomide—systemic scleroderma	0.000257	0.000622	CcSEcCtD
Metronidazole—Abdominal pain—Leflunomide—systemic scleroderma	0.000255	0.000619	CcSEcCtD
Metronidazole—Body temperature increased—Leflunomide—systemic scleroderma	0.000255	0.000619	CcSEcCtD
Metronidazole—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000254	0.000616	CcSEcCtD
Metronidazole—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000254	0.000615	CcSEcCtD
Metronidazole—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000254	0.000615	CcSEcCtD
Metronidazole—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000253	0.000614	CcSEcCtD
Metronidazole—Breast disorder—Methotrexate—systemic scleroderma	0.000253	0.000614	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000253	0.000613	CcSEcCtD
Metronidazole—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000253	0.000612	CcSEcCtD
Metronidazole—Hypersensitivity—Azathioprine—systemic scleroderma	0.000252	0.000611	CcSEcCtD
Metronidazole—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000252	0.000611	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000252	0.000611	CcSEcCtD
Metronidazole—Insomnia—Lisinopril—systemic scleroderma	0.000251	0.000609	CcSEcCtD
Metronidazole—Paraesthesia—Lisinopril—systemic scleroderma	0.000249	0.000604	CcSEcCtD
Metronidazole—Vomiting—Captopril—systemic scleroderma	0.000249	0.000604	CcSEcCtD
Metronidazole—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000248	0.000602	CcSEcCtD
Metronidazole—Rash—Captopril—systemic scleroderma	0.000247	0.000599	CcSEcCtD
Metronidazole—Dermatitis—Captopril—systemic scleroderma	0.000247	0.000599	CcSEcCtD
Metronidazole—Somnolence—Lisinopril—systemic scleroderma	0.000247	0.000598	CcSEcCtD
Metronidazole—Headache—Captopril—systemic scleroderma	0.000246	0.000595	CcSEcCtD
Metronidazole—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000245	0.000595	CcSEcCtD
Metronidazole—Dyspepsia—Lisinopril—systemic scleroderma	0.000244	0.000593	CcSEcCtD
Metronidazole—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000244	0.000591	CcSEcCtD
Metronidazole—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000244	0.000591	CcSEcCtD
Metronidazole—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000243	0.00059	CcSEcCtD
Metronidazole—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000243	0.00059	CcSEcCtD
Metronidazole—Asthma—Methotrexate—systemic scleroderma	0.000242	0.000588	CcSEcCtD
Metronidazole—Infection—Mycophenolate mofetil—systemic scleroderma	0.000242	0.000586	CcSEcCtD
Metronidazole—Decreased appetite—Lisinopril—systemic scleroderma	0.000241	0.000585	CcSEcCtD
Metronidazole—Eosinophilia—Methotrexate—systemic scleroderma	0.00024	0.000582	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00024	0.000581	CcSEcCtD
Metronidazole—Fatigue—Lisinopril—systemic scleroderma	0.000239	0.00058	CcSEcCtD
Metronidazole—Shock—Mycophenolate mofetil—systemic scleroderma	0.000239	0.00058	CcSEcCtD
Metronidazole—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000239	0.000578	CcSEcCtD
Metronidazole—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000238	0.000577	CcSEcCtD
Metronidazole—Hypersensitivity—Leflunomide—systemic scleroderma	0.000238	0.000577	CcSEcCtD
Metronidazole—Pancreatitis—Methotrexate—systemic scleroderma	0.000238	0.000576	CcSEcCtD
Metronidazole—Pain—Lisinopril—systemic scleroderma	0.000237	0.000576	CcSEcCtD
Metronidazole—Constipation—Lisinopril—systemic scleroderma	0.000237	0.000576	CcSEcCtD
Metronidazole—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000236	0.000573	CcSEcCtD
Metronidazole—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000235	0.00057	CcSEcCtD
Metronidazole—Diarrhoea—Azathioprine—systemic scleroderma	0.000234	0.000568	CcSEcCtD
Metronidazole—Nausea—Captopril—systemic scleroderma	0.000233	0.000565	CcSEcCtD
Metronidazole—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000232	0.000563	CcSEcCtD
Metronidazole—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000232	0.000562	CcSEcCtD
Metronidazole—Asthenia—Leflunomide—systemic scleroderma	0.000232	0.000562	CcSEcCtD
Metronidazole—Hallucination—Prednisone—systemic scleroderma	0.000231	0.00056	CcSEcCtD
Metronidazole—Pancytopenia—Methotrexate—systemic scleroderma	0.00023	0.000558	CcSEcCtD
Metronidazole—Feeling abnormal—Lisinopril—systemic scleroderma	0.000229	0.000555	CcSEcCtD
Metronidazole—Pruritus—Leflunomide—systemic scleroderma	0.000229	0.000554	CcSEcCtD
Metronidazole—Connective tissue disorder—Prednisone—systemic scleroderma	0.000228	0.000553	CcSEcCtD
Metronidazole—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000227	0.00055	CcSEcCtD
Metronidazole—Dysuria—Methotrexate—systemic scleroderma	0.000227	0.000549	CcSEcCtD
Metronidazole—Neutropenia—Methotrexate—systemic scleroderma	0.000227	0.000549	CcSEcCtD
Metronidazole—Dizziness—Azathioprine—systemic scleroderma	0.000226	0.000549	CcSEcCtD
Metronidazole—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000225	0.000546	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000222	0.000537	CcSEcCtD
Metronidazole—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000221	0.000536	CcSEcCtD
Metronidazole—Asthenia—Mycophenolic acid—systemic scleroderma	0.000221	0.000536	CcSEcCtD
Metronidazole—Diarrhoea—Leflunomide—systemic scleroderma	0.000221	0.000536	CcSEcCtD
Metronidazole—Urticaria—Lisinopril—systemic scleroderma	0.000221	0.000535	CcSEcCtD
Metronidazole—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00022	0.000533	CcSEcCtD
Metronidazole—Body temperature increased—Lisinopril—systemic scleroderma	0.00022	0.000532	CcSEcCtD
Metronidazole—Abdominal pain—Lisinopril—systemic scleroderma	0.00022	0.000532	CcSEcCtD
Metronidazole—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000218	0.00053	CcSEcCtD
Metronidazole—Pruritus—Mycophenolic acid—systemic scleroderma	0.000218	0.000529	CcSEcCtD
Metronidazole—Vomiting—Azathioprine—systemic scleroderma	0.000218	0.000527	CcSEcCtD
Metronidazole—Eye disorder—Prednisone—systemic scleroderma	0.000217	0.000526	CcSEcCtD
Metronidazole—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000216	0.000524	CcSEcCtD
Metronidazole—Infestation NOS—Methotrexate—systemic scleroderma	0.000216	0.000524	CcSEcCtD
Metronidazole—Infestation—Methotrexate—systemic scleroderma	0.000216	0.000524	CcSEcCtD
Metronidazole—Drowsiness—Methotrexate—systemic scleroderma	0.000216	0.000524	CcSEcCtD
Metronidazole—Rash—Azathioprine—systemic scleroderma	0.000216	0.000523	CcSEcCtD
Metronidazole—Dermatitis—Azathioprine—systemic scleroderma	0.000216	0.000523	CcSEcCtD
Metronidazole—Depression—Methotrexate—systemic scleroderma	0.000215	0.000522	CcSEcCtD
Metronidazole—Flushing—Prednisone—systemic scleroderma	0.000215	0.000522	CcSEcCtD
Metronidazole—Headache—Azathioprine—systemic scleroderma	0.000214	0.00052	CcSEcCtD
Metronidazole—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000214	0.000519	CcSEcCtD
Metronidazole—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000214	0.000519	CcSEcCtD
Metronidazole—Dizziness—Leflunomide—systemic scleroderma	0.000214	0.000518	CcSEcCtD
Metronidazole—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000212	0.000513	CcSEcCtD
Metronidazole—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000211	0.000511	CcSEcCtD
Metronidazole—Stomatitis—Methotrexate—systemic scleroderma	0.000211	0.000511	CcSEcCtD
Metronidazole—Angiopathy—Prednisone—systemic scleroderma	0.000211	0.000511	CcSEcCtD
Metronidazole—Conjunctivitis—Methotrexate—systemic scleroderma	0.00021	0.000509	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00021	0.000509	CcSEcCtD
Metronidazole—Immune system disorder—Prednisone—systemic scleroderma	0.00021	0.000508	CcSEcCtD
Metronidazole—Pain—Mycophenolate mofetil—systemic scleroderma	0.000208	0.000504	CcSEcCtD
Metronidazole—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000208	0.000504	CcSEcCtD
Metronidazole—Sweating—Methotrexate—systemic scleroderma	0.000207	0.000502	CcSEcCtD
Metronidazole—Vomiting—Leflunomide—systemic scleroderma	0.000205	0.000498	CcSEcCtD
Metronidazole—Hypersensitivity—Lisinopril—systemic scleroderma	0.000205	0.000496	CcSEcCtD
Metronidazole—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000204	0.000495	CcSEcCtD
Metronidazole—Dizziness—Mycophenolic acid—systemic scleroderma	0.000204	0.000494	CcSEcCtD
Metronidazole—Rash—Leflunomide—systemic scleroderma	0.000204	0.000494	CcSEcCtD
Metronidazole—Dermatitis—Leflunomide—systemic scleroderma	0.000204	0.000493	CcSEcCtD
Metronidazole—Mental disorder—Prednisone—systemic scleroderma	0.000203	0.000493	CcSEcCtD
Metronidazole—Nausea—Azathioprine—systemic scleroderma	0.000203	0.000493	CcSEcCtD
Metronidazole—Headache—Leflunomide—systemic scleroderma	0.000202	0.000491	CcSEcCtD
Metronidazole—Erythema—Prednisone—systemic scleroderma	0.000202	0.00049	CcSEcCtD
Metronidazole—Agranulocytosis—Methotrexate—systemic scleroderma	0.000202	0.000489	CcSEcCtD
Metronidazole—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000201	0.000486	CcSEcCtD
Metronidazole—Asthenia—Lisinopril—systemic scleroderma	0.000199	0.000483	CcSEcCtD
Metronidazole—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000199	0.000482	CcSEcCtD
Metronidazole—Pruritus—Lisinopril—systemic scleroderma	0.000196	0.000476	CcSEcCtD
Metronidazole—Vomiting—Mycophenolic acid—systemic scleroderma	0.000196	0.000475	CcSEcCtD
Metronidazole—Rash—Mycophenolic acid—systemic scleroderma	0.000194	0.000471	CcSEcCtD
Metronidazole—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000194	0.000471	CcSEcCtD
Metronidazole—Hepatitis—Methotrexate—systemic scleroderma	0.000194	0.00047	CcSEcCtD
Metronidazole—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000193	0.000469	CcSEcCtD
Metronidazole—Headache—Mycophenolic acid—systemic scleroderma	0.000193	0.000468	CcSEcCtD
Metronidazole—Pharyngitis—Methotrexate—systemic scleroderma	0.000193	0.000467	CcSEcCtD
Metronidazole—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000192	0.000466	CcSEcCtD
Metronidazole—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000192	0.000466	CcSEcCtD
Metronidazole—Nausea—Leflunomide—systemic scleroderma	0.000192	0.000465	CcSEcCtD
Metronidazole—CYP2C9—digestive system—systemic scleroderma	0.000191	0.0402	CbGeAlD
Metronidazole—Vision blurred—Prednisone—systemic scleroderma	0.00019	0.000462	CcSEcCtD
Metronidazole—Diarrhoea—Lisinopril—systemic scleroderma	0.00019	0.000461	CcSEcCtD
Metronidazole—Visual impairment—Methotrexate—systemic scleroderma	0.000187	0.000453	CcSEcCtD
Metronidazole—Angioedema—Prednisone—systemic scleroderma	0.000185	0.000448	CcSEcCtD
Metronidazole—Dizziness—Lisinopril—systemic scleroderma	0.000184	0.000445	CcSEcCtD
Metronidazole—Erythema multiforme—Methotrexate—systemic scleroderma	0.000183	0.000445	CcSEcCtD
Metronidazole—Nausea—Mycophenolic acid—systemic scleroderma	0.000183	0.000444	CcSEcCtD
Metronidazole—Malaise—Prednisone—systemic scleroderma	0.000182	0.000442	CcSEcCtD
Metronidazole—Vertigo—Prednisone—systemic scleroderma	0.000182	0.00044	CcSEcCtD
Metronidazole—Eye disorder—Methotrexate—systemic scleroderma	0.000181	0.000439	CcSEcCtD
Metronidazole—Syncope—Prednisone—systemic scleroderma	0.000181	0.000439	CcSEcCtD
Metronidazole—Tinnitus—Methotrexate—systemic scleroderma	0.000181	0.000438	CcSEcCtD
Metronidazole—Cardiac disorder—Methotrexate—systemic scleroderma	0.00018	0.000436	CcSEcCtD
Metronidazole—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000179	0.000435	CcSEcCtD
Metronidazole—Loss of consciousness—Prednisone—systemic scleroderma	0.000178	0.000431	CcSEcCtD
Metronidazole—Vomiting—Lisinopril—systemic scleroderma	0.000177	0.000428	CcSEcCtD
Metronidazole—Angiopathy—Methotrexate—systemic scleroderma	0.000176	0.000427	CcSEcCtD
Metronidazole—Immune system disorder—Methotrexate—systemic scleroderma	0.000175	0.000425	CcSEcCtD
Metronidazole—Rash—Lisinopril—systemic scleroderma	0.000175	0.000424	CcSEcCtD
Metronidazole—Convulsion—Prednisone—systemic scleroderma	0.000175	0.000424	CcSEcCtD
Metronidazole—Dermatitis—Lisinopril—systemic scleroderma	0.000175	0.000424	CcSEcCtD
Metronidazole—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000175	0.000424	CcSEcCtD
Metronidazole—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000175	0.000423	CcSEcCtD
Metronidazole—Hypertension—Prednisone—systemic scleroderma	0.000174	0.000423	CcSEcCtD
Metronidazole—Headache—Lisinopril—systemic scleroderma	0.000174	0.000422	CcSEcCtD
Metronidazole—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000172	0.000417	CcSEcCtD
Metronidazole—Arthralgia—Prednisone—systemic scleroderma	0.000172	0.000417	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000171	0.000414	CcSEcCtD
Metronidazole—Mental disorder—Methotrexate—systemic scleroderma	0.00017	0.000412	CcSEcCtD
Metronidazole—Erythema—Methotrexate—systemic scleroderma	0.000169	0.000409	CcSEcCtD
Metronidazole—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000166	0.000404	CcSEcCtD
Metronidazole—Dysgeusia—Methotrexate—systemic scleroderma	0.000165	0.000401	CcSEcCtD
Metronidazole—Nausea—Lisinopril—systemic scleroderma	0.000165	0.0004	CcSEcCtD
Metronidazole—Anaphylactic shock—Prednisone—systemic scleroderma	0.000165	0.0004	CcSEcCtD
Metronidazole—Oedema—Prednisone—systemic scleroderma	0.000165	0.0004	CcSEcCtD
Metronidazole—Infection—Prednisone—systemic scleroderma	0.000164	0.000397	CcSEcCtD
Metronidazole—Back pain—Methotrexate—systemic scleroderma	0.000163	0.000396	CcSEcCtD
Metronidazole—Shock—Prednisone—systemic scleroderma	0.000162	0.000393	CcSEcCtD
Metronidazole—Nervous system disorder—Prednisone—systemic scleroderma	0.000162	0.000392	CcSEcCtD
Metronidazole—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000161	0.00039	CcSEcCtD
Metronidazole—Skin disorder—Prednisone—systemic scleroderma	0.00016	0.000388	CcSEcCtD
Metronidazole—Hyperhidrosis—Prednisone—systemic scleroderma	0.000159	0.000386	CcSEcCtD
Metronidazole—Vision blurred—Methotrexate—systemic scleroderma	0.000159	0.000386	CcSEcCtD
Metronidazole—Anorexia—Prednisone—systemic scleroderma	0.000157	0.000381	CcSEcCtD
Metronidazole—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000155	0.000375	CcSEcCtD
Metronidazole—Rash—Mycophenolate mofetil—systemic scleroderma	0.000153	0.000372	CcSEcCtD
Metronidazole—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000153	0.000372	CcSEcCtD
Metronidazole—Headache—Mycophenolate mofetil—systemic scleroderma	0.000152	0.000369	CcSEcCtD
Metronidazole—Malaise—Methotrexate—systemic scleroderma	0.000152	0.000369	CcSEcCtD
Metronidazole—Vertigo—Methotrexate—systemic scleroderma	0.000152	0.000368	CcSEcCtD
Metronidazole—Leukopenia—Methotrexate—systemic scleroderma	0.000151	0.000366	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.00015	0.000364	CcSEcCtD
Metronidazole—Insomnia—Prednisone—systemic scleroderma	0.000149	0.000362	CcSEcCtD
Metronidazole—Paraesthesia—Prednisone—systemic scleroderma	0.000148	0.000359	CcSEcCtD
Metronidazole—Convulsion—Methotrexate—systemic scleroderma	0.000146	0.000355	CcSEcCtD
Metronidazole—CYP3A4—digestive system—systemic scleroderma	0.000146	0.0307	CbGeAlD
Metronidazole—Dyspepsia—Prednisone—systemic scleroderma	0.000145	0.000352	CcSEcCtD
Metronidazole—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000145	0.00035	CcSEcCtD
Metronidazole—Arthralgia—Methotrexate—systemic scleroderma	0.000144	0.000349	CcSEcCtD
Metronidazole—Chest pain—Methotrexate—systemic scleroderma	0.000144	0.000349	CcSEcCtD
Metronidazole—Decreased appetite—Prednisone—systemic scleroderma	0.000143	0.000348	CcSEcCtD
Metronidazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000143	0.000346	CcSEcCtD
Metronidazole—Fatigue—Prednisone—systemic scleroderma	0.000142	0.000345	CcSEcCtD
Metronidazole—Constipation—Prednisone—systemic scleroderma	0.000141	0.000342	CcSEcCtD
Metronidazole—Confusional state—Methotrexate—systemic scleroderma	0.000139	0.000337	CcSEcCtD
Metronidazole—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000138	0.000334	CcSEcCtD
Metronidazole—Infection—Methotrexate—systemic scleroderma	0.000137	0.000332	CcSEcCtD
Metronidazole—Feeling abnormal—Prednisone—systemic scleroderma	0.000136	0.000329	CcSEcCtD
Metronidazole—Nervous system disorder—Methotrexate—systemic scleroderma	0.000135	0.000328	CcSEcCtD
Metronidazole—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000135	0.000327	CcSEcCtD
Metronidazole—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000135	0.000327	CcSEcCtD
Metronidazole—Skin disorder—Methotrexate—systemic scleroderma	0.000134	0.000325	CcSEcCtD
Metronidazole—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000133	0.000323	CcSEcCtD
Metronidazole—Anorexia—Methotrexate—systemic scleroderma	0.000131	0.000318	CcSEcCtD
Metronidazole—Urticaria—Prednisone—systemic scleroderma	0.000131	0.000318	CcSEcCtD
Metronidazole—Abdominal pain—Prednisone—systemic scleroderma	0.00013	0.000316	CcSEcCtD
Metronidazole—Body temperature increased—Prednisone—systemic scleroderma	0.00013	0.000316	CcSEcCtD
Metronidazole—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000126	0.000304	CcSEcCtD
Metronidazole—Insomnia—Methotrexate—systemic scleroderma	0.000125	0.000302	CcSEcCtD
Metronidazole—Paraesthesia—Methotrexate—systemic scleroderma	0.000124	0.0003	CcSEcCtD
Metronidazole—Somnolence—Methotrexate—systemic scleroderma	0.000123	0.000297	CcSEcCtD
Metronidazole—Hypersensitivity—Prednisone—systemic scleroderma	0.000122	0.000295	CcSEcCtD
Metronidazole—Dyspepsia—Methotrexate—systemic scleroderma	0.000121	0.000294	CcSEcCtD
Metronidazole—Decreased appetite—Methotrexate—systemic scleroderma	0.00012	0.00029	CcSEcCtD
Metronidazole—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000119	0.000288	CcSEcCtD
Metronidazole—Fatigue—Methotrexate—systemic scleroderma	0.000119	0.000288	CcSEcCtD
Metronidazole—Asthenia—Prednisone—systemic scleroderma	0.000118	0.000287	CcSEcCtD
Metronidazole—Pain—Methotrexate—systemic scleroderma	0.000118	0.000286	CcSEcCtD
Metronidazole—Pruritus—Prednisone—systemic scleroderma	0.000117	0.000283	CcSEcCtD
Metronidazole—Feeling abnormal—Methotrexate—systemic scleroderma	0.000114	0.000275	CcSEcCtD
Metronidazole—Diarrhoea—Prednisone—systemic scleroderma	0.000113	0.000274	CcSEcCtD
Metronidazole—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000113	0.000273	CcSEcCtD
Metronidazole—Urticaria—Methotrexate—systemic scleroderma	0.000109	0.000265	CcSEcCtD
Metronidazole—Dizziness—Prednisone—systemic scleroderma	0.000109	0.000264	CcSEcCtD
Metronidazole—Abdominal pain—Methotrexate—systemic scleroderma	0.000109	0.000264	CcSEcCtD
Metronidazole—Body temperature increased—Methotrexate—systemic scleroderma	0.000109	0.000264	CcSEcCtD
Metronidazole—Vomiting—Prednisone—systemic scleroderma	0.000105	0.000254	CcSEcCtD
Metronidazole—Rash—Prednisone—systemic scleroderma	0.000104	0.000252	CcSEcCtD
Metronidazole—Dermatitis—Prednisone—systemic scleroderma	0.000104	0.000252	CcSEcCtD
Metronidazole—Headache—Prednisone—systemic scleroderma	0.000103	0.00025	CcSEcCtD
Metronidazole—Hypersensitivity—Methotrexate—systemic scleroderma	0.000102	0.000246	CcSEcCtD
Metronidazole—Asthenia—Methotrexate—systemic scleroderma	9.89e-05	0.00024	CcSEcCtD
Metronidazole—Nausea—Prednisone—systemic scleroderma	9.8e-05	0.000237	CcSEcCtD
Metronidazole—Pruritus—Methotrexate—systemic scleroderma	9.75e-05	0.000236	CcSEcCtD
Metronidazole—Diarrhoea—Methotrexate—systemic scleroderma	9.43e-05	0.000229	CcSEcCtD
Metronidazole—Dizziness—Methotrexate—systemic scleroderma	9.11e-05	0.000221	CcSEcCtD
Metronidazole—Vomiting—Methotrexate—systemic scleroderma	8.76e-05	0.000212	CcSEcCtD
Metronidazole—Rash—Methotrexate—systemic scleroderma	8.69e-05	0.000211	CcSEcCtD
Metronidazole—Dermatitis—Methotrexate—systemic scleroderma	8.68e-05	0.00021	CcSEcCtD
Metronidazole—Headache—Methotrexate—systemic scleroderma	8.63e-05	0.000209	CcSEcCtD
Metronidazole—Nausea—Methotrexate—systemic scleroderma	8.19e-05	0.000198	CcSEcCtD
